Influence of Hyaluronic Acid on Bacillus Calmette-Guérin Local Side Effects

NCT02207608 ↗

Phase 2 Completed 30 enrolled University of Rome Tor Vergata

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate a possible role of intravesical Hyaluronic Acid in reducing local toxicity of Bacillus Calmette Guerin (BCG) used to treat bladder urothelial cell carcinoma.

Timeline

Start: 2011-09
Primary completion: 2012-08
Completion: 2012-08

Publications

Topazio L, Miano R, Maurelli V, Gaziev G, Gacci M, Iacovelli V, Finazzi-Agro E. Could hyaluronic acid (HA) reduce Bacillus Calmette-Guerin (BCG) local side effects? Results of a pilot study. BMC Urol. 2014 Aug 13;14:64. doi: 10.1186/1471-2490-14-64.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Hyaluronic Acid	Other / unclassified	40 mg	Other
Background	Mycobax	Vaccine	81 mg	Other

Indications

No indication recorded.